journal article·2024-06-10

Electrophoresis-Based Approach for Characterizing Dendrimer–Protein Interactions: A Proof-of-Concept Study

Simone A. Douglas-Green, Juan A. Aleman, Paula T. Hammond

Publisher page

Abstract

Improving the clinical translation of nanomedicine requires better knowledge about how nanoparticles interact with biological environments. As researchers are recognizing the importance of understanding the protein corona and characterizing how nanocarriers respond in biological systems, new tools and techniques are needed to analyze nanocarrier-protein interactions, especially for smaller size (<10 nm) nanoparticles like polyamidoamine (PAMAM) dendrimers. Here, we developed a streamlined, semiquantitative approach to assess dendrimer-protein interactions using a nondenaturing electrophoresis technique combined with mass spectrometry. With this protocol, we detect fluorescently tagged dendrimers and proteins simultaneously, enabling us to analyze when dendrimers migrate with proteins. We found that PAMAM dendrimers mostly interact with complement proteins, particularly C3 and C4a, which aligns with previously published data, verifying that our approach can be used to isolate and identify dendrimer-protein interactions.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Dendrimers and Hyperbranched Polymers · RNA Interference and Gene Delivery · Polymer Surface Interaction Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Ave, Cambridge, Massachusetts 02139, United States

Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, 500 Main St, Cambridge, Massachusetts 02142, United States

Funding

Ford Foundation · National Institute of Biomedical Imaging and Bioengineering · Massachusetts Institute of Technology · Congressionally Directed Medical Research Programs · Burroughs Wellcome Fund

References (58)

Show source-provided references
1. 10.1002/advs.20170089710.1002/advs.201700897 ↗
2. 10.3390/biom912079010.3390/biom9120790 ↗
3. 10.1016/j.apmt.2018.05.00210.1016/j.apmt.2018.05.002 ↗
4. 10.1016/j.colsurfb.2021.11183710.1016/j.colsurfb.2021.111837 ↗
5. 10.3390/ijms2206291210.3390/ijms22062912 ↗
6. 10.1155/2014/50727310.1155/2014/507273 ↗
7. 10.1007/s00289-019-03076-410.1007/s00289-019-03076-4 ↗
8. 10.1126/scitranslmed.aat880010.1126/scitranslmed.aat8800 ↗
9. 10.1039/D2SM01698B10.1039/D2SM01698B ↗
10. 10.2147/IJN.S12930010.2147/IJN.S129300 ↗
11. 10.1039/D0AN00633E10.1039/D0AN00633E ↗
12. 10.1002/etc.392410.1002/etc.3924 ↗
13. 10.1038/s41578-023-00552-210.1038/s41578-023-00552-2 ↗
14. 10.1073/pnas.080513510510.1073/pnas.0805135105 ↗
15. 10.1016/j.apsb.2020.10.02310.1016/j.apsb.2020.10.023 ↗
16. 10.3390/app922478910.3390/app9224789 ↗
17. 10.1002/SMLL.20200216210.1002/SMLL.202002162 ↗
18. 10.3390/nano1204068210.3390/nano12040682 ↗
19. 10.3389/fbioe.2020.0016610.3389/fbioe.2020.00166 ↗
20. 10.1016/j.ijpharm.2018.10.01110.1016/j.ijpharm.2018.10.011 ↗
21. 10.1016/j.bbamem.2009.11.00710.1016/j.bbamem.2009.11.007 ↗
22. 10.1016/j.biomaterials.2011.08.04810.1016/j.biomaterials.2011.08.048 ↗
23. 10.3389/fimmu.2020.56736510.3389/fimmu.2020.567365 ↗
24. 10.1039/C5NR08196C10.1039/C5NR08196C ↗
25. 10.1021/acs.biomac.9b0053910.1021/acs.biomac.9b00539 ↗
26. 10.1039/C5NR02618K10.1039/C5NR02618K ↗
27. 10.1039/C9NA00537D10.1039/C9NA00537D ↗
28. 10.1021/acsnano.8b0350010.1021/acsnano.8b03500 ↗
29. 10.1039/c2ra21866f10.1039/c2ra21866f ↗
30. 10.1002/elps.20060080710.1002/elps.200600807 ↗
31. 10.1016/j.cis.2018.06.00510.1016/j.cis.2018.06.005 ↗
32. 10.1021/mp200463e10.1021/mp200463e ↗
33. 10.1039/D2SM01698B10.1039/D2SM01698B ↗
34. 10.3762/bjnano.10.10110.3762/bjnano.10.101 ↗
35. 10.2147/IJN.S12930010.2147/IJN.S129300 ↗
36. Mathew J. · 2024
37. 10.1021/cr068287r10.1021/cr068287r ↗
38. 10.5851/kosfa.2022.e4610.5851/kosfa.2022.e46 ↗
39. 10.1007/s00216-022-04278-y10.1007/s00216-022-04278-y ↗
40. 10.1016/j.ab.2022.11478810.1016/j.ab.2022.114788 ↗
41. 10.1021/la051726h10.1021/la051726h ↗
42. 10.1016/j.actbio.2016.07.01510.1016/j.actbio.2016.07.015 ↗
43. 10.1159/00037142310.1159/000371423 ↗
44. 10.1016/S0927-7765(99)00156-310.1016/S0927-7765(99)00156-3 ↗
45. 10.1016/j.molimm.2008.08.27610.1016/j.molimm.2008.08.276 ↗
46. 10.2147/IJN.S19221410.2147/IJN.S192214 ↗
47. 10.1038/nnano.2016.26910.1038/nnano.2016.269 ↗
48. Bombelli F. B. · Eur. Cell Mater. · 2010 · 20 · 10
49. 10.1021/mp900092610.1021/mp9000926 ↗
50. Bert J. L. · 1985 · 521
51. 10.1016/j.jconrel.2019.04.02310.1016/j.jconrel.2019.04.023 ↗
52. 10.1016/j.colsurfb.2015.07.01710.1016/j.colsurfb.2015.07.017 ↗
53. 10.1039/C8PY01399C10.1039/C8PY01399C ↗
54. 10.1016/j.colsurfa.2006.04.03510.1016/j.colsurfa.2006.04.035 ↗
55. 10.1021/jp011035410.1021/jp0110354 ↗
56. 10.1111/j.1365-313X.2007.03316.x10.1111/j.1365-313X.2007.03316.x ↗
57. 10.1002/pmic.20090015110.1002/pmic.200900151 ↗
58. 10.1021/bc070008z10.1021/bc070008z ↗